Bone Biologics Corp (BBLG) stock
BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.29−0.02 (-5.92%)
Close on Nov 18, 2026Market cap $986.22KP/E –Yield –
Bone Biologics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Bone Biologics's operating income for the twelve months ending Sep 30, 2026 was -$3.01M. For fiscal 2025 it was -$3.23M. The highest annual figure on record is -$825.01K in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$3.23M | – |
| FY2024 | Dec 31, 2024 | -$4.22M | – |
| FY2023 | Dec 31, 2023 | -$9.43M | – |
| FY2022 | Dec 31, 2022 | -$3.67M | – |
| FY2021 | Dec 31, 2021 | -$1.10M | – |
| FY2020 | Dec 31, 2020 | -$825.01K | – |
| FY2019 | Dec 31, 2019 | -$2.45M | – |
| FY2018 | Dec 31, 2018 | -$2.79M | – |
| FY2017 | Dec 31, 2017 | -$2.63M | – |
| FY2016 | Dec 31, 2016 | -$20.41M | – |
| FY2015 | Dec 31, 2015 | -$12.00M | – |
| FY2014 | Dec 31, 2014 | -$3.01M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$666.34K | – |
| Q2 FY2026 | Jun 30, 2026 | -$808.11K | – |
| Q1 FY2026 | Mar 31, 2026 | -$805.05K | – |
| Q4 FY2025 | Dec 31, 2025 | -$733.11K | – |
| Q3 FY2025 | Sep 30, 2025 | -$715.27K | – |
| Q2 FY2025 | Jun 30, 2025 | -$748.08K | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.04M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.55M | – |
| Q3 FY2024 | Sep 30, 2024 | -$951.02K | – |
| Q2 FY2024 | Jun 30, 2024 | -$809.67K | – |
| Q1 FY2024 | Mar 31, 2024 | -$903.54K | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.16M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.08M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.04M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.15M | – |
| Q2 FY2022 | Jun 30, 2022 | -$469.30K | – |
| Q1 FY2022 | Mar 31, 2022 | -$689.50K | – |
| Q4 FY2021 | Dec 31, 2021 | -$460.48K | – |
| Q3 FY2021 | Sep 30, 2021 | -$229.79K | – |
| Q2 FY2021 | Jun 30, 2021 | -$231.88K | – |
| Q1 FY2021 | Mar 31, 2021 | -$180.92K | – |
| Q4 FY2020 | Dec 31, 2020 | -$206.43K | – |
| Q3 FY2020 | Sep 30, 2020 | -$145.82K | – |
| Q2 FY2020 | Jun 30, 2020 | -$132.71K | – |
| Q1 FY2020 | Mar 31, 2020 | -$340.05K | – |
| Q4 FY2019 | Dec 31, 2019 | -$277.63K | – |
| Q3 FY2019 | Sep 30, 2019 | -$301.31K | -174.4% |
| Q2 FY2019 | Jun 30, 2019 | -$679.26K | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.19M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.24M | – |
| Q3 FY2018 | Sep 30, 2018 | $404.79K | – |
| Q2 FY2018 | Jun 30, 2018 | -$860.15K | -143.6% |
| Q1 FY2018 | Mar 31, 2018 | -$1.10M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.31M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.13M | – |
| Q2 FY2017 | Jun 30, 2017 | $1.97M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.16M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.11M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.86M | – |
See a number that looks wrong?